semaglutide drugs list FDA approves Wegovy pill and changes everything about GLP-1 Why weight-loss drugs became more

In the journal JAMA Ophthalmology , Harvard scientists found that patients whod been prescribed semaglutide a glucagon-like peptide-1 (GLP-1) agonist believed to mimic the stomachs feeling of fullness were between four and seven times as likely to develop non-arteritic anterior ischemic optic neuropathy, a condition that blocks blood flow to eye nerves, than people prescribed other weight loss drugs

The co-activation of both receptors in retatrutide may therefore reduce appetite through two partially independent central pathways, which could explain why the compounds appetite-suppressing effects exceed what GLP-1R agonism alone achieves

It also helps regulate blood sugar levels

Inhibition of caspase-3 activity and activation by protein glutathionylation